Your browser doesn't support javascript.
loading
Lenalidomide before and after autologous stem cell transplantation for transplant-eligible patients of all ages in the randomized, phase III, Myeloma XI trial.
Jackson, Graham H; Davies, Faith E; Pawlyn, Charlotte; Cairns, David A; Striha, Alina; Collett, Corinne; Waterhouse, Anna; Jones, John R; Kishore, Bhuvan; Garg, Mamta; Williams, Cathy D; Karunanithi, Kamaraj; Lindsay, Jindriska; Allotey, David; Shafeek, Salim; Jenner, Matthew W; Cook, Gordon; Russell, Nigel H; Kaiser, Martin F; Drayson, Mark T; Owen, Roger G; Gregory, Walter M; Morgan, Gareth J; Clinical Studies Group, Uk Ncri Haematological Oncology.
Afiliación
  • Jackson GH; Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, UK.
  • Davies FE; Perlmutter Cancer Center, NYU Langone Health, New York, USA.
  • Pawlyn C; The Institute of Cancer Research and The Royal Marsden Hospital NHS Foundation Trust, London, UK.
  • Cairns DA; Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, UK.
  • Striha A; Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, UK.
  • Collett C; Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, UK.
  • Waterhouse A; Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, UK.
  • Jones JR; Kings College Hospital NHS Foundation Trust, London, UK.
  • Kishore B; Heart of England NHS Foundation Trust, Birmingham, UK.
  • Garg M; Leicester Royal Infirmary, Leicester, UK.
  • Williams CD; Centre for Clinical Haematology, Nottingham University Hospital, Nottingham, UK.
  • Karunanithi K; University Hospital of North Midlands, Stoke-on-Trent, UK.
  • Lindsay J; East Kent Hospitals University NHS Foundation Trust, Canterbury, UK.
  • Allotey D; Derby Teaching Hospitals NHS Foundation Trust, Derby, UK.
  • Shafeek S; Worcestershire Acute Hospitals NHS Trust, Worcester, UK.
  • Jenner MW; University Hospital Southampton NHS Foundation Trust, Southampton, UK.
  • Cook G; Section of Experimental Haematology, Leeds Institute of Cancer and Pathology, University of Leeds, UK.
  • Russell NH; Centre for Clinical Haematology, Nottingham University Hospital, Nottingham, UK.
  • Kaiser MF; The Institute of Cancer Research and The Royal Marsden Hospital NHS Foundation Trust, London, UK.
  • Drayson MT; Clinical Immunology, School of Immunity and Infection, University of Birmingham, UK.
  • Owen RG; St James's University Hospital, Haematological Malignancy Diagnostic Service (HMDS), Leeds, UK.
  • Gregory WM; Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, UK.
  • Morgan GJ; Perlmutter Cancer Center, NYU Langone Health, New York, USA.
Haematologica ; 106(7): 1957-1967, 2021 07 01.
Article en En | MEDLINE | ID: mdl-32499244
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Mieloma Múltiple Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Haematologica Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Mieloma Múltiple Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Haematologica Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido